Xie, Junqiu
Li, Yao
Li, Jing
Yan, Zhibin
Wang, Dan
Guo, Xiaomin
Zhang, Jianfeng
Zhang, Bangzhi
Mou, Lingyun
Yang, Wenle
Jiang, Xianxing
Funding for this research was provided by:
National Natural Science Foundation of China (81602945, 81673283, 81473095)
Program for Ministry of Education “Peptide Drugs” Innovation Team (IRT_15R27)
China Postdoctoral Science Foundation (2016M592593)
Fundamental Research Funds for the Central Universities (lzujbky-2017-k11, lzujbky-2017-119)
Fundamental Research Funds for the Central Universities (lzujbky-2017-139)
Article History
Received: 15 April 2018
Accepted: 18 July 2018
First Online: 22 August 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: This article does not contain any studies with human participants performed by any other authors. All experiments involving animals were performed in strict compliance with the directions of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The official procedure was approved by the Ethics Committee of Lanzhou University (Permit Number: SYXK Gan 2013-0003), China.